Association of FOS-Like Antigen 1 Promoter Polymorphism with Podocyte Foot Process Effacement in Immunoglobulin A Nephropathy Patients

Journal of Clinical Laboratory Analysis

Volumn 28, Issue 5, 2014, Pages 391-397

  Park, Hae Jeong ^a   Kim, Jong Woo ^a   Cho, Byoung Soo ^a   Chung, Joo Ho ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

FOS; FOS like antigen 1; Immunoglobulin A nephropathy; Podocyte foot process effacement; Single nucleotide polymorphism

Indexed keywords

FOS LIKE ANTIGEN 1; FOS LIKE ANTIGEN 2; PROTEIN; PROTEIN FOS; TRANSCRIPTION FACTOR FOSB; UNCLASSIFIED DRUG; PROTEIN C FOS; TRANSCRIPTION FACTOR FRA 1;

ALLELE; ARTICLE; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; DISEASE MARKER; DNA POLYMORPHISM; FEMALE; GENOTYPE; HEMATURIA; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; MALE; MESANGIUM CELL; MULTIGENE FAMILY; PHENOTYPE; PODOCYTE; PROMOTER REGION; PROTEINURIA; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; ADULT; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLOMERULONEPHRITIS, IGA; HUMANS; MALE; MIDDLE AGED; PODOCYTES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-FOS; YOUNG ADULT;

EID: 84906934658     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21699     Document Type: Article

References (21)

1. Boyd JK, Cheung CK, Molyneux K, Feehally J, Barratt J. An update on the pathogenesis and treatment of IgA nephropathy. Kidney Int 2012;81:833-843.
2. Koyama A, Igarashi M, Kobayashi M. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases. Am J Kidney Dis 1997;29:526-532.
3. Barratt J, Feehally J. Primary IgA nephropathy: New insights into pathogenesis. Semin Nephrol 2011;31:349-360.
4. Katafuchi R, Oh Y, Hori K, et al. An important role of glomerular segmental lesions on progression of IgA nephropathy: A multivariate analysis. Clin Nephrol 1994;41:191-198.
5. Abe T, Kida H, Yoshimura M, et al. Participation of extracapillary lesions (ECL) in progression of IgA nephropathy. Clin Nephrol 1986;25:37-41.
6. Borioli GA. Immediate early proto-oncoproteins and membranes: Not just an innocent liaison. Curr Protein Pept Sci 2011;12:685-690.
7. Takemura T, Okada M, Akano N, et al. Proto-oncogene expression in human glomerular diseases. J Pathol 1996;178:343-351.
8. Rastaldi MP, Tunesi S, Ferrario F, et al. Transforming growth factor-beta, endothelin-1, and c-fos expression in necrotizing/crescentic IgA glomerulonephritis. Nephrol Dial Transplant 1998;13:1668-1674.
9. Ebihara I, Nakamura T, Suzuki S, Tomino Y, Koide H. Proto-oncogene expression in peripheral blood mononuclear cells in IgA nephropathy. Kidney Int 1991;39:946-953.
10. Lee HS, Lee MS, Lee SM, et al. Histological grading of IgA nephropathy predicting renal outcome: Revisiting H. S. Lee's glomerular grading system. Nephrol Dial Transplant 2005;20:342-348.
11. Nakanishi K, Sako M, Yata N, et al. A-20C angiotensinogen gene polymorphism and proteinuria in childhood IgA nephropathy. Pediatr Nephrol 2004;19:144-147.
12. Maruyama K, Yoshida M, Nishio H, et al. Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy. Pediatr Nephrol 2001;16:350-355.
13. Durchdewald M, Angel P, Hess J. The transcription factor Fos: A Janus-type regulator in health and disease. Histol Histopathol 2009;24:1451-1461.
14. Hsu SI, Ramirez SB, Winn MP, Bonventre JV, Owen WF. Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int 2000;57:1818-1835.
15. Yamamoto R, Nagasawa Y, Shoji T, et al. A candidate gene approach to genetic contributors to the development of IgA nephropathy. Nephrol Dial Transplant 2012;27:1020-1030.
16. Yamamoto R, Nagasawa Y, Shoji T, et al. A candidate gene approach to genetic prognostic factors of IgA nephropathy-A result of polymorphism research to distinguish genetic factors contributing to progression of IgA nephropathy (PREDICT-IgAN). Nephrol Dial Transplant 2009;24:3686-3694.
17. Coppo R, Camilla R, Amore A, Peruzzi L. Oxidative stress in IgA nephropathy. Nephron Clin Pract 2010;116:c196-c198, discussion c199.
18. Patino WD, Mian OY, Kang JG, et al. Circulating transcriptome reveals markers of atherosclerosis. Proc Natl Acad Sci USA 2005;102:3423-3428.
19. Sharma SG, Spencer T, Gokden N. The significance of foot process effacement in immunoglobulin A nephropathy: Clinicopathologic study of 161 cases with light, immunofluorescence and electron microscopic studies. Ultrastruct Pathol 2010;34:269-272.
20. Deegens JK, Dijkman HB, Borm GF, et al. Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis. Kidney Int 2008;74:1568-1576.
21. Pagtalunan ME, Miller PL, Jumping-Eagle S, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997;99:342-348.